Search Results

In a paper published in Science Translational Medicine, researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, report that they have discovered advances in predicting kidney failure in type 1 diabetes patients.

Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR® blood glucose monitoring system portfolio and distributors of the Eversense® continuous glucose monitoring system, was named as an honoree at the Joslin Diabetes Center High Hopes Gala, to celebrate the 100th Anniversary of Insulin, held on November 13th.

Roughly 11 percent of people living in the United States have type 2 diabetes and nearly 40 percent of adults have prediabetes, according to the Centers for Disease Control and Prevention.

Researchers with City of Hope®, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, presented novel study results at the 84th Scientific Sessions of ADA held June 21 to 24 in Orlando, Florida.

The agency’s inertia and bureaucratic roadblocks are throttling hope for millions of patients. A new center of excellence would provide a solution.

Kubota Vision Inc., a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., announced that the Company and Joslin Diabetes Center have entered into a material transfer and collaboration agreement for our Patient Based Ophthalmology Suite, in-home optical coherence tomography device.